Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03771820
Title Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors NanoCarrier Co., Ltd

head and neck squamous cell carcinoma



NC-6004 + Pembrolizumab

Age Groups: adult | senior
Covered Countries

No variant requirements are available.